Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Back to Forecasting
BAX Forecast Markets
Baxter International
7
Active Markets
36%
Avg Probability
All Markets
7 markets
Will Baxter's Novum LVP shipment hold be lifted by December 31, 2026?
28%
Likely No
92% agreement
Feb 28, 2027
IG: 0.80
Will Baxter's FY2026 free cash flow exceed $500M?
38%
Likely No
94% agreement
Feb 28, 2027
IG: 0.80
Will Baxter's IV Solutions segment show positive organic revenue growth in Q2 2026?
20%
Likely No
96% agreement
Aug 15, 2026
IG: 0.64
Will Baxter record a goodwill impairment charge in FY2026?
58%
Likely Yes
94% agreement
Mar 15, 2027
IG: 0.48
Will Baxter's FY2026 adjusted EPS exceed the high end of guidance ($2.05)?
25%
Likely No
92% agreement
Feb 28, 2027
IG: 0.48
Will Baxter's Advanced Surgery segment sustain 8%+ organic growth through H1 2026?
48%
Likely No
92% agreement
Aug 15, 2026
IG: 0.48
Will Baxter's total 2026 tariff-related cost impact exceed $175M?
32%
Likely No
94% agreement
Feb 28, 2027
IG: 0.48
Resolution Timeline
Aug 15, 2026
Will Baxter's IV Solutions segment show positive organic revenue growth in Q2 2026?Prediction: 20%
Aug 15, 2026
Will Baxter's Advanced Surgery segment sustain 8%+ organic growth through H1 2026?Prediction: 48%
Feb 28, 2027
Will Baxter's FY2026 adjusted EPS exceed the high end of guidance ($2.05)?Prediction: 25%